Quick Answer
BioScience Health Innovations, Inc. reported Cash and Equivalents of $661.9 thousand for fiscal year 2025.
BioScience Health Innovations, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $661.9K | -0.1% |
| 2024 | $662.5K | +3343.8% |
| 2023 | $19.2K | +66.3% |
| 2022 | $11.6K | +468.5% |
| 2021 | $2.0K | -90.1% |
| 2020 | $20.6K | — |
| 2019 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.14M | +241.9% | -12.3% |
| June 30, 2025 | $1.30M | +802.9% | +26.4% |
| March 31, 2025 | $1.03M | +1006.5% | +55.2% |
| December 31, 2024 | $662.5K | +3343.8% | +98.8% |
| September 30, 2024 | $333.2K | +693.6% | +131.5% |
| June 30, 2024 | $143.9K | +374.7% | +54.9% |
| March 31, 2024 | $92.9K | +882.0% | +383.1% |
| December 31, 2023 | $19.2K | +66.3% | -54.2% |
- BioScience Health Innovations, Inc. showed a decrease of -0.1% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: